We analyzed the expression of these genes in clinical GBM specimens using The Cancer Genome Atlas and Chinese Glioma Genome Atlas datasets and found a significant positive correlation between fibulin-3 and this immunosuppressive signature (Fig. 2A; Supplementary Fig. S3). Here, EFEMP1 is linked to central nervous system cancer.